Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-09-000111
Filing Date
2009-02-05
Accepted
2009-02-05 15:25:00
Documents
1
Period of Report
2009-01-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 5934
  Complete submission text file 0001123292-09-000111.txt   8565
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 890 WINTER STREET WALTHAM MA 02451
Business Address 890 WINTER STREET WALTHAM MA 02451 7816221700
Atlas Venture Fund VII L P (Reporting) CIK: 0001346450 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 09572872

Mailing Address 890 WINTER STREET WALTHAM MA 02451
Business Address 890 WINTER STREET WALTHAM MA 02451 781 622 1700
Atlas Venture Associates VII, L.P. (Reporting) CIK: 0001377726 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 09572871